Skip to main navigation Skip to search Skip to main content

Corrigendum to “Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer” [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270–280] (Gynecologic Oncology (2022) 165(2) (270–280), (S0090825822001767), (10.1016/j.ygyno.2022.03.005))

  • Jung In Shim
  • , Ji Yoon Ryu
  • , Soo Young Jeong
  • , Young Jae Cho
  • , Jung Joo Choi
  • , Jae Ryoung Hwang
  • , Ju Yeon Choi
  • , Jason K. Sa
  • , Jeong Won Lee
  • Sungkyunkwan University
  • Hallym University
  • Korea University

Research output: Contribution to journalComment/debate

Abstract

The authors regret that Figure 6 was published truncated and data C was missing. Full Figure 6 can be found below. The authors would like to apologise for any inconvenience caused.[Formula

Original languageEnglish
Pages (from-to)370-371
Number of pages2
JournalGynecologic Oncology
Volume166
Issue number2
DOIs
StatePublished - Aug 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer” [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270–280] (Gynecologic Oncology (2022) 165(2) (270–280), (S0090825822001767), (10.1016/j.ygyno.2022.03.005))'. Together they form a unique fingerprint.

Cite this